Publication Name	World Journal of Gastroenterology
Manuscript ID	15793
Country	Brazil

Received	2014-12-09 08:15
Peer-Review Started	2014-12-09 08:35
To Make the First Decision	2015-01-08 16:51
Return for Revision	2015-01-16 10:36
Revised	2015-01-27 08:48
Second Decision	2015-02-10 21:28
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-02-11 15:58
Articles in Press	2015-02-11 16:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-03-23 17:29
Publish the Manuscript Online	2015-04-07 17:13

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Adjuvant therapy for gastric cancer: What have we learned since INT0116?
Manuscript Source	Invited Manuscript
All Author List	Alexandre A Jácome, Ajith K Sankarankutty and José Sebastião dos Santos
Funding Agency and Grant Number	Funding Agency Grant Number Fundação Waldemar Barnsley Pessoa, Brazil
Corresponding Author	Alexandre A Jácome, MD, PhD, Department of Medical Oncology, Hospital Mater Dei, Av. Barbacena, 1057, Belo Horizonte 30190-131, Minas Gerais, Brazil. jacome@usp.br
Key Words	Stomach neoplasms; Adjuvant radiotherapy; Adjuvant chemotherapy; Histology; Genes erbB-2
Core Tip	Adjuvant therapy of gastric cancer significantly improves overall survival. The most accepted adjuvant therapy in the Western world is chemoradiotherapy according to the pivotal INT0116 study. However, in the time following its publication, other adjuvant treatment modalities have been discussed, and significant improvements have been obtained in our understanding of the multimodal approach of gastric cancer. The present review reports on the major advances obtained in the last decades in the adjuvant treatment of gastric cancer as well as the perspectives of treatment based on recent knowledge of the molecular biology of the disease.
Publish Date	2015-04-07 17:13
Citation	Jácome AA, Sankarankutty AK, dos Santos JS. Adjuvant therapy for gastric cancer: What have we learned since INT0116? World J Gastroenterol 2015; 21(13): 3850-3859
URL	http://www.wjgnet.com/1007-9327/full/v21/i13/3850.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i13.3850

Full Article (PDF)	WJG-21-3850.pdf
Full Article (Word)	WJG-21-3850.doc
Manuscript File	15793-Review.docx
Answering Reviewers	15793-Answering reviewers.pdf
Audio Core Tip	15793-Audio core tip.aiff
Copyright License Agreement	15793-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	15793-Language certificate.pdf
Peer-review Report	15793-Peer-review(s).pdf
Scientific Misconduct Check	15793-Scientific misconduct check.pdf
Scientific Editor Work List	15793-Scientific editor work list.pdf